Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V0355CP3A vs Ferrograd in iron deficiency anaemia
2007-004139-49Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Tardyferon in iron deficiency anemia (IDA) (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Haemoglobin level change and tolerability at 12 weeks. Started Dec 2007; status: completed.
02
Drugs
Tardyferon
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2007-004139-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004139-49.